PharMerica Reports Third Quarter 2016 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- SK Hynix’s record plunge drags down global chip stocks
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- Ditching streaming could boost Disney stock by 40%, Wells Fargo says
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
Pharmerica (PMC) Misses Q3 EPS by 7c; Guides FY16 Below Views
November 9, 2016 8:09 AM ESTPharmerica (NYSE: PMC) reported Q3 EPS of $0.44, $0.07 worse than the analyst estimate of $0.51. Revenue for the quarter came in at $512.6 million versus the consensus estimate of $530.01 million.
GUIDANCE:
Pharmerica sees FY2016 EPS of $1.84-$1.89, versus the consensus of $2.01. Pharmerica sees FY2016... More
